(Q63570826)
Statements
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of RA101495 in Subjects With Generalized Myasthenia Gravis (English)
0 references
11 October 2017
0 references
10 December 2018
0 references
44
0 references
18 year
0 references
85 year
0 references